Skip to main content
. 2021 Dec 22;13:778527. doi: 10.3389/fnagi.2021.778527

Figure 1.

Figure 1

Fibroblast growth factor 21 (FGF21) treatment prevented the motor deficits of mice with PD. (A) Schematic of the experimental procedure. (B) Time to descend pole. (C) Rotarod test. (D) Track of mice in open field test. (E) Distance traveled in the center for 5 min. Data are mean ± s.e.m.; n = 6–8 for each group. One-way ANOVA was conducted for statistical analysis followed by an LSD multiple comparison test. **P < 0.01 vs. control (CON) group; #P < 0.05, ###P < 0.001 vs. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-injected mice.